Prednisone Trial and Additional Testing for Suspected Gout
Yes, initiate oral prednisone for this patient with suspected acute gout who has failed indomethacin therapy, and perform synovial fluid aspiration with crystal analysis to confirm the diagnosis.
Immediate Management: Switch to Prednisone
Given the inadequate response to indomethacin, switching to oral corticosteroids is appropriate and evidence-based. Oral prednisolone (35 mg once daily for 5 days) has been shown to be equally effective as NSAIDs for acute gout treatment 1, 2. The 2016 RCT demonstrated equivalent pain reduction between prednisolone and indomethacin (44.7 mm vs 46.0 mm on visual analog scale after 90 hours), with prednisolone actually having fewer adverse events during the acute phase (6% vs 19%) 1.
Dosing Recommendation:
- Prednisone 30-35 mg orally once daily for 5 days is the evidence-based regimen 1, 2
- No tapering is necessary for this short duration
- Expect significant pain reduction within 24-48 hours
Critical Diagnostic Testing: Synovial Fluid Analysis
The most important next step is joint aspiration with synovial fluid crystal analysis, which remains the gold standard for gout diagnosis 3. The 2017 ACP guideline specifically recommends synovial fluid analysis when clinical judgment indicates diagnostic testing is necessary in patients with possible acute gout 3.
Why This Matters:
- Normal X-rays do NOT rule out gout—radiographic changes typically appear only after years of disease 3
- The exquisite tenderness to light touch raises concern for septic arthritis, which can mimic gout and requires urgent differentiation 4
- Crystal analysis provides definitive diagnosis and prevents misdiagnosis of infection masquerading as gout 4
What to Look For:
- Monosodium urate crystals (needle-shaped, negatively birefringent under polarized light microscopy)
- Gram stain and culture to exclude septic arthritis
- White blood cell count in synovial fluid
Additional Diagnostic Considerations
Serum Uric Acid Level:
- Obtain serum uric acid, but interpret cautiously—levels can be normal or even low during acute flares 5
- More useful for long-term management planning than acute diagnosis
Advanced Imaging (If Aspiration Not Feasible):
- Ultrasound can detect double contour sign, erosions, tophi, and synovial hypertrophy with high sensitivity 5, 6
- Dual-energy CT can identify urate deposits 3, 5
- These are alternatives only if joint aspiration is unsuccessful or not feasible 5
Common Pitfalls to Avoid
Do not assume gout based on clinical presentation alone when infection cannot be excluded—the patient's severe pain with light touch is concerning 4
Do not delay aspiration because of normal X-rays—radiographic changes are late findings 3
Do not interpret normal serum uric acid as excluding gout—up to 30% of patients have normal levels during acute attacks 5
Do not start urate-lowering therapy (allopurinol) during the acute flare unless already established on it—this can worsen the attack 7
If Gout is Confirmed
Once diagnosis is established and the acute flare resolves:
- Consider initiating urate-lowering therapy with low-dose allopurinol (≤100 mg/day, lower if CKD present) with gradual titration 7
- Provide anti-inflammatory prophylaxis (colchicine, NSAIDs, or low-dose prednisone) for 3-6 months when starting urate-lowering therapy 7
The 2020 ACR guideline strongly recommends allopurinol as first-line urate-lowering therapy for all patients, including those with CKD stage ≥3 7.